- Summary
- Price Reports
- Price History
- Add To Your Stocklist
- View your Stocklist
- Basic Chart
- Interactive Chart
- Headlines
- Company Snapshot
- Summary Reports
- Free Annual Report
- Estimate Snapshot
- Estimate Report
- Mobile Quote
- Real-Time Quote
- Streaming Quote
|
Transition Therapeutics Inc | Company Snapshot
-
![]()
-
-
-
Vol:
-
Last Trade:
|
TRANSITION THERAPEUTICS INC
TRANSITION THERAPEUTICS INC. is a fully integrated biopharmaceutical company with a proprietary drug discovery engine and drug development program in multiple disease indications including alzheimer's disease and diabetes.
|
|
| Symbol: |
TTH |
| Exchange(s): |
Toronto Stock Exchange |
| Industry: |
Consumer Products (Biotechnology & Pharmaceuticals) |
| 5-Star Rating: |
 |
|
ANNUAL FINANCIALS
|
|
|
Jun 30, 2009
12 Months
C$
|
Jun 30, 2008
12 Months
C$
|
Jun 30, 2007
12 Months
C$
|
3Yr.
Growth
% Change
|
|
Total Revenue ($000)
|
5,906
|
4,622
|
1,910
|
147.62
|
|
Earnings before Interest & Tax ($000)
|
-22,070
|
-16,769
|
-20,077
|
N/A
|
|
Profit/Loss ($000)
|
-22,374
|
-16,119
|
-16,962
|
N/A
|
|
Earnings per Share
|
-0.97
|
-0.70
|
-0.87
|
N/A
|
|
Total Assets ($000)
|
72,819
|
94,876
|
63,996
|
18.17
|
|
Dividends Per Share
|
0.00
|
0.00
|
0.00
|
|
|
Return on Com. Equity
|
-41.59
|
-28.28
|
-39.62
|
|
|
Employees
|
28
|
36
|
34
|
|
|
|
|
|
Trailing 12 Month Results
|
|
|
12 Months ended
Sep 30, 2009, C$
|
12 Months ended
Sep 30, 2008, C$
|
%Change
|
|
Total Revenue ($000)
|
6,264
|
5,063
|
23.73
|
|
Profit/Loss ($000)
|
-22,955
|
-17,053
|
-34.61
|
|
Earnings per Share
|
-0.99
|
-0.75
|
-32.00
|
|
Dividends Per Share
|
0.00
|
0.00
|
|
Number of Shares
|
23,217,047
|
23,215,160
|
|
|
|
|
|
COMPANY INFORMATION
|
|
Report on Business Magazine Top 1000 Ranking
|
| Profit: 0789 |
Revenue: 0841 |
Assets: 0756 |
|
|
|
| Key Personnel |
| CEO: Dr. Tony F. Cruz, Chairman & C.E.O. |
| |
| Contact Information |
| Address: |
101 College St.,
Suite 220,
Toronto,
ON,
M5G 1L7 |
Phone: |
416-260-7770 |
| Fax: |
416-260-2886 |
| Web Address: |
www.transitiontherapeutics.com |
| E-Mail : |
info@transitiontherapeutics.com |
| Investor Relations: |
Elie Farah, 416-260-7770 |
| |
| Company Type: |
Public |
Company Status: |
Active |
| Auditors: |
Pricewaterhousecoopers Llp |
| Transfer Agent: |
Computershare Trust Co. Of Can Toronto |
| Incorporation:
| Ontario, Jul 6, 1998 |
| |
|
Securities:
|
TTHI-Q TTH-T
|
|
| |
|
|
| |
|
|
All information on this site is compiled by CTVglobemedia Publishing Inc. from reliable industry sources. While all efforts are made to ensure the accuracy of the information, CTVglobemedia Publishing Inc. and its related entities assume no liability for incorrect, incomplete, or missing information from this site. Past performance is not necessarily indicative of future performance. Prior to making any investment decision, consult with a qualified investment advisor.
Copyright © 2010 CTVglobemedia Publishing Inc. All rights reserved.
|
|
|
